Featured
Managing Anxiety and Uncertainty in Polycythemia Vera
Vaccine News Oct 21, 2026
Clinic Moves Oct 20, 2026
Vaccine News Oct 19, 2026
Five U.S. hospitals rank among the world’s top oncology centers in 2027, showcasing one of...
The FDA approves ropeginterferon alfa-2b-njft for essential thrombocythemia, the first new treatment for the rare...
Breast cancer diagnosis taught Dr. Molly Greenwade, an oncologist, lessons on early detection while juggling...
Read our latest Drug Approvals articles.
Therapeutic phlebotomy is one of the key treatments for managing polycythemia vera risks, helping lower...
Most breast bruises are not linked to breast cancer unless they persist beyond two weeks,...
Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and...
Managing anxiety and uncertainty in polycythemia vera is possible with these coping strategies. Learn how patients handle stress and keep hematocrit levels low.
Managing anxiety and uncertainty in polycythemia vera is possible with these coping strategies. Learn how patients handle stress and keep...
Five U.S. hospitals rank among the world’s top oncology centers in 2027, showcasing one of the strongest cancer treatment networks...
Managing fatigue with polycythemia vera involves balancing energy levels and daily activities to maintain well-being while participating in life's pursuits.
Long-term, stage-based journey of multiple myeloma treatment, understanding what to expect at each phase.
New myelofibrosis treatments offer hope and improve quality of life, with patient-focused strategies from the NCCN guiding management.
Therapeutic phlebotomy is one of the key treatments for managing polycythemia vera risks, helping lower hematocrit levels below 45% to...
Most breast bruises are not linked to breast cancer unless they persist beyond two weeks, involving deeper bleeding and pain.
The FDA approves ropeginterferon alfa-2b-njft for essential thrombocythemia, the first new treatment for the rare blood cancer in nearly 30...
Black Americans face over double the multiple myeloma risk compared to white Americans, yet reasons remain unexplained.
Patients can effectively advocate for their polycythemia vera care needs by preparing for medical visits and communicating symptoms.